Meningioma
📧 Sign up to get email alerts when something new happens for Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating REC-2282 in progressive NF2-mutated meningiomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Pharmacoscopy for Patients With Refractory Primary Brain Tumors [Phase 2]
Phase 2 clinical trial update for pharmacoscopy in patients with refractory primary brain tumors, currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial [Phase 2]
This Phase IIc randomized feasibility pilot trial evaluated cognitive behavioral therapy for insomnia in patients with primary brain tumors …
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI
Clinical trial update on preselecting patients with meningioma at risk for cognitive decline after radiotherapy using advanced MRI; the stud…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: 177Lu-DOTATATE for Recurrent Meningioma [Phase 2]
Phase 2 clinical trial update for 177Lu-DOTATATE in recurrent meningioma; the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors [NA]
This ClinicalTrials.gov entry describes a recruiting study comparing proton versus photon radiotherapy in adults with primary brain tumors, …
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: 9-ING-41 in Pediatric Patients With Refractory Malignancies. [Phase 1]
Phase 1 trial of 9-ING-41 in pediatric patients with refractory malignancies was terminated; the update does not include study results.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Trabectedin for Recurrent Grade II/III Meningioma [Phase 2]
Phase 2 trial of trabectedin for recurrent grade II/III meningioma has been completed with results posted.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating a dual-targeting tracer TATE-RGD for imaging SSTR- and RGD-positive tumors. The study targets iod…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Long-Term Longitudinal QoL in Patients Undergoing EEA
ClinicalTrials.gov registry entry from Ohio State University indicates ongoing recruitment for a long-term quality-of-life study in patients…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma [NA]
Clinical trial update on the Optune NovoTTF-100A device for recurrent atypical and anaplastic meningioma; the pilot study is active but not …
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas
Translation and validation of the MQOL self-questionnaire into French to assess quality of life in patients with meningiomas.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma [Phase 2]
A Phase 2 trial is evaluating the combination of Optune's tumor treating fields therapy with Bevacizumab for patients with recurrent or prog…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: [NA]
This ClinicalTrials.gov entry describes a recruiting study comparing neurocognitive outcomes of different irradiation methods in patients wi…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma [Phase 1, Phase 2]
A clinical trial update for boron neutron capture therapy using B-10 L-BPA in recurrent meningioma; Phase 1/2, currently active but not recr…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide
A multicenter study evaluating the response of meningioma to treatment with lutetium-177 dotatate has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Embolization for Meningioma [NA]
A clinical trial is evaluating embolization as a treatment for meningioma and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma [Phase 1]
This Phase 1 trial assesses the feasibility of using hyperpolarized imaging to study meningioma in patients.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors [Phase 1]
Phase 1 study evaluating panobinostat with stereotactic radiation therapy for brain tumors, including recurrent glioma, high-grade meningiom…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
A clinical trial evaluating how endoscopic endonasal skull base surgery impacts olfactory function in patients with meningioma and pituitary…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors [Phase 2]
Phase 2 trial of selumetinib in Neurofibromatosis type II–related tumors was terminated, with results posted in 2025; the study included ves…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: DOTATATE PET for Meningioma Radiation Planning [NA]
A clinical trial update for DOTATATE PET imaging being studied to aid radiation planning in meningioma; the study status is not yet recruiti…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the radiolabeled somatostatin antagonist 177Lu-satoreotide for recurrent or progressive meningiomas…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Predictive Factors for Survival in Aggressive Meningiomas [NA]
This entry reports an ongoing clinical study assessing predictors of survival in aggressive meningiomas (including typical, atypical, and an…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial [Phase 2]
A Phase IIb trial is evaluating the combination of Everolimus and Lutetium-177 dotatate for grades 2 and 3 refractory meningioma, currently …